Gujarat Kidney And Super Speciality IPO Details
The Gujarat Kidney And Super Speciality IPO is a book build issue with a total issue size of ₹250.8 cr, comprising of fresh issue of 22000000 equity shares. Gujarat Kidney And Super Speciality IPO opened for subscription on Dec 22, 2025 and closed on Dec 24, 2025. Gujarat Kidney And Super Speciality IPO is set price band at ₹108 to ₹114 per share, with a lot size of 128 shares. Minimum investment for Retail investors was ₹14,592.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Dec 26, 2025, and listed on both the NSE and BSE on Dec 30, 2025.
MUFG Intime India Private Limited has been appointed as the registrar. **Nirbhay Capital Services Private Limited ** are the Book Running Lead Manager for the issue.
Before investing in the Gujarat Kidney And Super Speciality IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 108 – 114
- Lot Size
- 128
- Issue Size
- ₹250.8 Cr
- Minimum Investment
- ₹14592 (128 Shares)
- Listing Date
- 30 December 2025
Current GMP
₹1 (+0.88%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Gujarat Kidney And Super Speciality Limited
Incorporated in 2019, Gujarat Kidney & Super Speciality Limited (“GKASSL”) is a regional multispeciality healthcare provider offering secondary and tertiary care services across multiple locations in Gujarat, India. The company operates a network of multispeciality hospitals supported by in-house pharmacy and diagnostic services, catering to both private patients and beneficiaries under government healthcare schemes such as Ayushman Bharat – PMJAY.
As of June 30, 2025, GKASSL operated seven multispeciality hospitals and four pharmacies with an aggregate infrastructure of 490 total beds, including 455 approved beds and 340 operational beds. Its hospital network includes Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand), along with Ashwini Medical Store (Anand).
The company provides a comprehensive range of medical services spanning:
- Secondary Care Services: General medicine and general surgical treatments
- Tertiary Care Services: Super speciality surgical procedures
Gujarat Superspeciality Hospital delivers care across multiple clinical disciplines, including internal medicine, general and minimally invasive surgery, orthopaedics and trauma care, joint replacement, obstetrics and gynaecology, respiratory care, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company employed 759 personnel, comprising 89 doctors, 332 nurses, and 338 other staff members.
Competitive Strengths
- Established presence in renal sciences with sub-superspeciality expertise in urology
- Asset-light operating model with a strategic focus on central Gujarat
- Ability to attract and retain skilled and experienced medical professionals
- Proven track record of operational scale-up and financial growth
As of March 20, 2025, Gujarat Kidney & Super Speciality operated six multispeciality hospitals and three in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand, with consolidated infrastructure of 400 total beds, including 355 approved beds and 250 operational beds. The workforce at that time comprised 322 personnel, including 47 doctors, 138 nurses, 21 full-time consultants, and 32 visiting consultants.
In line with its expansion strategy, the company is acquiring Parekhs Hospital, Ahmedabad—a 49-bed facility (including 8 ICU beds) commissioned in 2006—for ₹77 crore, funded through net proceeds, further strengthening its footprint in Gujarat’s underpenetrated healthcare markets.
Gujarat Kidney And Super Speciality IPO Promoters
- Dr. Pragnesh Yashwantsinh Bharpoda
- Dr. Bhartiben Pragnesh Bharpoda
- Dr. Yashwantsingh Motisinh Bharpoda
- Anitaben Yashwantsinh Bharpoda
Promoters Holding
Holding Pre Issue
99.10%
Holding Post Issue
71.45%
Gujarat Kidney And Super Speciality IPO Objective
The Company Gujarat Kidney And Super Speciality IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Proposed acquisition of Parekhs Hospital at Ahmedabad
- Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”
- Funding of capital expenditure requirements of our Company towards setting up of a new hospital in Vadodara
- Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company
- Funding inorganic growth through unidentified acquisitions and General Corporate Purposes
Address / Contact Info
Gujarat Kidney & Super Speciality Limited
Plot No. 1, City Sarve No. 1537/A,
Jetalpur Road, Gokak Mill Compound,
Alkapuri, Vadodara , Gujarat, India
Vadodara, Gujarat, 390020
Phone: +91 265 298 48
Email: info@gujaratsuperspecialityhospital.com
IPO Snapshot
Gujarat Kidney And Super Speciality IPO Registrar
MUFG Intime India Private Limited
Check Allotment StatusBook Running Lead Managers
- Nirbhay Capital Services Private Limited
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Gujarat Kidney And Super Speciality IPO is a Book-building IPO with a total issue size of ₹250.8 crore. The Gujarat Kidney And Super Speciality IPO price band is ₹108 to 114 per share. The Gujarat Kidney And Super Speciality IPO subscription opens on Mon, Dec 22, 2025, and closes on Wed, Dec 24, 2025. The Gujarat Kidney And Super Speciality IPO will be listed on the BSE,NSE. MUFG Intime India Private Limited is the registrar for the Gujarat Kidney And Super Speciality IPO .
The Gujarat Kidney And Super Speciality IPO opens on Mon, Dec 22, 2025 and closes on Wed, Dec 24, 2025
Gujarat Kidney And Super Speciality IPO Price Band is ₹108 to 114 per share.
Gujarat Kidney And Super Speciality IPO lot size is 128 shares, Retail investors need a minimum investment of ₹14592 based on the upper price band
The minimum investment for Gujarat Kidney And Super Speciality IPO is ₹14592, based on one lot of 128 shares at the upper price band of ₹114 per share.
Investors can apply for the Gujarat Kidney And Super Speciality IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Wed, Dec 24, 2025. The application amount remains blocked until the Gujarat Kidney And Super Speciality IPO allotment is finalized.
Gujarat Kidney And Super Speciality IPO issue size is ₹250.8 crores.
Gujarat Kidney And Super Speciality IPO allotment date is Wed, Jul 1, 2026.
The registrar for Gujarat Kidney And Super Speciality IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Gujarat Kidney And Super Speciality IPO allotment status, refund processing, and other IPO-related information.
The Gujarat Kidney And Super Speciality IPO GMP (Grey Market Premium) is ₹1 as of Tue, Dec 30, 2025. Based on the upper price band of ₹114 per share, the estimated Gujarat Kidney And Super Speciality IPO listing price is ₹115, indicating a potential listing gain of approximately 0% over the issue price.